And as a result, there are pretty strict barriers to entry
In a new article for Life Science Daily News, Dr Jasmine Sayyari, CEO and Founder of Lean Health, sets out what the clinical data actually show, what the British regulatory runway looks like gate by gate, and what this means for the GLP-1 market, bariatric providers, and NHS commissioners facing what she describes as "the most expensive non-specialist prescribing question in a generation." The science is moving fast
There are two specific safety risks with compounded injectable GLP-1s that go beyond standard medication side effects, and both have been the subject of public regulatory and legal attention in 2025-2026
One of the few locations on the body that are susceptible to sun exposure and sun damage on darker skin types is the bottom lip
Verify the dose-escalation pricing structure with any platform before committing